Back to Trades
RECURSION PHARMACEUTICALS, INC.
RXRXCIK: 0001601830
Follow RXRX
Track RECURSION PHARMACEUTICALS, INC. insider trades on your dashboard. Email alerts with a subscription.
RECURSION PHARMACEUTICALS, INC. (RXRX) has recorded 50 insider filings from 11 unique insiders, totaling $8.2M in trading activity (net selling). Insiders have sold $6.0M while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Borgeson Blake. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$8.2M
Purchases
$0
Sales
$6.0M
Unique Insiders
11
Recent Insider Trades
50 loaded
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Bumpus Namandje | Director | Sell | $12.6K |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Sun Elaine D | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Director | Grant | $0 |
| Jun 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Michor Franziska | Director | Grant | $0 |
| Jun 17 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Other | $0 |
| Jun 5 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Sell | $84.5K |
| Jun 5 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $144.8K |
| Jun 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Bumpus Namandje | Director | Sell | $15.5K |
| Jun 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $110.4K |
| May 27 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $123.2K |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Other | $0 |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Other | $0 |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Other | $0 |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Other | $0 |
| May 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $134.8K |
| May 7 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $105.6K |
| Apr 24 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $144.4K |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $93.0K |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $124.0K |
| Apr 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Other | $0 |
| Mar 25 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $130.0K |
| Mar 18 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Sell | $27.0K |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Other | $0 |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $138.4K |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Sell | $41.4K |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Other | $0 |
| Feb 10 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | CEO and President, Director | Grant | $0 |
| Feb 10 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Grant | $0 |
| Feb 10 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Grant | $0 |
| Feb 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $164.8K |
| Feb 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $924.0K |
| Jan 22 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $178.8K |
| Jan 8 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $959.2K |
| Jan 7 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Sell | $170.0K |
| Jan 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Li Dean Y | Director | Grant | $0 |
| Jan 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Director | Grant | $0 |
| Dec 30 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Sell | $89.4K |
| Dec 29 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | Chief R&D Commercial Officer, Director | Sell | $548.6K |
| Dec 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $180.0K |
| Dec 17 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Other | $0 |
| Dec 4 | RXRX RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Sell | $961.4K |
| Nov 26 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Other | $0 |
| Nov 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $166.4K |
| Nov 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Taylor Ben R | Chief Financial Officer | Other | $0 |
| Nov 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | Chief R&D Commercial Officer, Director | Other | $0 |
| Nov 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Khan Najat | Chief R&D Commercial Officer, Director | Grant | $0 |
| Nov 6 | RXRX RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Chief Executive Officer, Director | Sell | $208.4K |
50 filings+